People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Other Health Care, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Proteus Biomedical Inc | — | Other Health Care | Series D+ | $162.4M | $2.7B | 2009 |
| Naurex Inc. | — | Biotechnology | Series C | $156.0M | $3.3B | 2011 |
| Light Sciences Oncology Inc | — | Biotechnology | Series B | $45.0M | $80.4M | 2011 |
| Incline Therapeutics, Inc. | — | Biotechnology | Series B | $43.9M | $853.3M | 2009 |
| Neuraltus Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $40.6M | $462.7M | 2009 |
| Atox Bio Inc. | — | Biotechnology | Series B | $35.1M | $1.3B | 2017 |
Terry Gould at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Terry Gould on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Walker | 1 | 17 |
| James Topper | 1 | 12 |
| Peter Bisgaard | 1 | 9 |
| Dennis Langer | 1 | 9 |
| Mitchell S. Bloom | 1 | 7 |
| Alan Levy | 1 | 7 |
| Erez Chimovits | 1 | 7 |
| Ryan Schwarz | 1 | 7 |
| Immanuel Thangaraj | 1 | 6 |
| Casper Breum | 1 | 5 |
| Frank Fischer | 1 | 5 |
| Jeff Himawan | 1 | 4 |
| Norbert Riedel | 1 | 4 |
| Theodore R. Schroeder | 1 | 4 |
| Daniel Burgess | 1 | 4 |
| Todd Thompson | 1 | 4 |
| James Woody | 1 | 4 |
| Jim Young | 1 | 4 |
| Derek Small | 1 | 4 |
| Annette Bianchi | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.